U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
--------------------------------------------------------------------------------
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): March 6, 2002
AMEDISYS, INC.
--------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
Delaware
-------------------------------
(State or Other Jurisdiction of
Incorporation or Organization)
0-24260 11-3131700
------------------------ ------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
11100 Mead Road, Suite 300, Baton Rouge, LA 70816
-----------------------------------------------------------
(Address of principal executive offices including zip code)
(225) 292-2031
(Registrant's telephone number, including area code)
ITEM 9. REGULATION FD DISCLOSURE
On March 6, 2002, representatives of Amedisys, Inc. (the
"Company") will begin making presentations at investor conferences
using slides containing the information attached to this Current Report
on Form 8-K as Exhibit 99.1. We are furnishing the text of these slides
pursuant to the Securities and Exchange Commission's Regulation FD.
This information is furnished pursuant to Item 9 of Form 8-K and shall
not be deemed to be "filed" for the purposes of Section 18 of the
Securities Exchange Act of 1934 or otherwise subject to the liabilities
of that Section, unless we specifically incorporates it by reference in
a document filed under the Securities Act of 1934. The Company expects
to use these slides, in whole or in part, and possibly with
modifications, in connection with presentations to investors, analysts
and others during 2002.
By filing this report on Form 8-K and furnishing this
information, we make no admission as to the materiality of any
information in this report that is required to be disclosed solely by
reason of Regulation FD.
The information contained in the slides is summary information
that is intended to be considered in the context of our Securities and
Exchange Commission ("SEC") filings and other public announcements that
we may make, by press release or otherwise, from time to time. We
undertake no duty or obligation to publicly update or revise the
information contained in this report, although we may do so from time
to time as our management believes is warranted. Any such updating may
be made through the filing of other reports or documents with the SEC,
through press releases or through other public disclosure.
When included in this Current Report on Form 8-K, the words
"expects", "intends", "anticipates", "believes", "estimates", and
analogous expressions are intended to identify forward-looking
statements. Such statements inherently are subject to a variety of
risks and uncertainties that could cause actual results to differ
materially from those projected. Such risks and uncertainties include,
among others, general economic and business conditions, current cash
flows and operating deficits, debt service needs, adverse changes in
federal and state laws relating to the health care industry,
competition, regulatory initiatives and compliance with governmental
regulations, customer preferences and various other matters, many of
which are beyond the Company's control. These forward-looking
statements speak only as of the date of the Current Report on Form 8-K.
The Company expressly disclaims any obligation or undertaking to
release publicly any updates or any changes in the Company's
expectations with regard thereto or any changes in events, conditions
or circumstances on which any statement is based.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(a) Financial Statements of Business Acquired.
Not applicable.
(b) Pro Forma Financial Information.
Not applicable.
(c) Exhibit
No. Page
99.1 (i) Text of Investor Relations Slide
Show in use beginning March 6, 2002...........A-1
(i) Filed herewith.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
AMEDISYS, INC.
By: /s/ LARRY GRAHAM
---------------------------------------
Larry Graham
Principal Accounting and Financial Officer
DATE: March 6, 2002
INDEX TO EXHIBITS
EXHIBIT
NUMBER DESCRIPTION
------- -----------
99.1 (i) Text of Investor Relations Slide Show in use beginning
March 6, 2002
----------
(i) Filed herewith.